Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Compositions and methods for rendering tumor cells susceptible to CD8+ T cell-mediated killing

Compositions and methods for rendering tumor cells susceptible to CD8+ T cell-mediated killing

US Patent 10183985 · Granted Jan 22, 2019

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Non-invasive cancer detection and analysis by single-molecule imaging2025
Non-invasive cancer detection and analysis by single-molecule imaging2025
Compositions comprising albumin-FMS-like tyrosine kinase 3 ligand fusion protein2025
Compositions comprising albumin-FMS-like tyrosine kinase 3 ligand fusion protein2025
Compositions and methods for enhancing an immune response2024
Methods for enhancing antigen-specific immune responses2023
Mesothelin vaccines and model systems2022
Compositions comprising albumin-FMS-like tyrosine kinase 3 ligand fusion protein2022
Compositions comprising albumin-FMS-like tyrosine kinase 3 ligand fusion protein2022
Methods for enhancing antigen-specific immune responses2020
Mesothelin vaccines and model systems2019
Superior molecular vaccine linking the translocation domain of a bacterial toxin2017